Prosecution Insights
Last updated: October 02, 2026

Examiner: XU, QING

Tech Center 1600 • Art Units: 1653 1655 1656

This examiner grants 51% of resolved cases

Analysis

Qing Xu serves as an examiner in Tech Center 1600 and Art Unit 1653. The examiner has 289 resolved cases, with an allowance rate of 50.9 percent. This rate indicates that approximately half of the applications reaching a final disposition are granted. Practitioners can use this 50.9 percent figure to set realistic expectations for the probability of success.

The profile indicates an interview lift of 55.2 percent. This metric shows a significant increase in the likelihood of allowance when an interview is conducted compared to the base allowance rate. For the 289 resolved cases, the 55.2 percent lift suggests that the examiner is very responsive to direct communication, making interviews a key strategy in Art Unit 1653.

The median days to allowance for this examiner is 1318. This pendency data reflects the typical time required for an application to reach a grant. By considering the 50.9 percent allowance rate and the 1318-day median, applicants can better plan their prosecution timelines and resource allocation when their applications are assigned to this examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

50.9%
Allow Rate
-9.1% vs TC avg
322
Total Applications
+55.2%
Interview Lift
1318
Avg Prosecution Days
Based on 289 resolved cases, 2023–2026

Rejection Statute Breakdown

6.4%
§101 Eligibility
15.8%
§102 Novelty
33.9%
§103 Obviousness
29.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17780412 METHODS AND COMPOSITIONS FOR PROMOTING PLANT GROWTH AND ROOT NODULATION Non-Final OA BASF Corporation
17769626 MONOLAYER CELL PATCH IN AN EXTRACELLULAR MATRIX SCAFFOLD Non-Final OA Carnegie Mellon University
17778269 CELL AGGREGATE, PRODUCING METHOD FOR MANUFACTURING CELL AGGREGATE, PRODUCING KIT FOR CELL AGGREGATE, AND CHEMICAL COMPOUND EVALUATING METHOD USING CELL AGGREGATE Final Rejection The University of Tokyo
17421917 FERMENTATION BROTHS AND THEIR USE Final Rejection EVONIK OPERATIONS GMBH
18503854 BIOREMEDIATION USING CO-METABOLISM SUBSTRATES Final Rejection North Carolina State University
17778452 POLYPEPTIDES HAVING PROTEOLYTIC ACTIVITY AND USE THEREOF Non-Final OA Novozymes A/S
18628884 MICROBIAL COMPOSITIONS COMPRISING RUMEN MICROFLORA AND USES THEREOF Non-Final OA The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization
18286315 OPTICAL CLEARING AND AUTO-FLUORESCENCE QUENCHING SOLUTIONS AND METHOD OF USE FOR ENHANCED MICROSCOPY IMAGING OF BIOLOGICAL TISSUES Non-Final OA CORNELL UNIVERSITY
17915500 VARIANTS OF BETA-GLUCOCEREBROSIDASE FOR USE IN TREATING GAUCHER DISEASE Final Rejection Yeda Research and Development Co. Ltd.
18007689 METHOD AND KIT FOR QUANTIFICATION OF LIPOPROTEIN CHOLESTEROL Final Rejection Denka Company Limited
17449723 COMPOUNDS AND METHODS FOR TREATING LIVER DISEASES Non-Final OA Eberhard Karls Universität Tübingen Medizinische Fakultät
18450986 SYSTEMS AND METHODS FOR METHANOL PRODUCTION Final Rejection WasteFuel Global LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month